Associated Papers
PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma.
Mohan A et al.
The Oncologist, 2024
Genomics driven precision oncology in advanced biliary tract cancer improves survival.
Kumar-Sinha C et al.
Neoplasia (new York, N.y.), 2023
Select a paper to view details